Generated: December 18, 2017
DrugPatentWatch Database Preview
DEXAMETHASONE SODIUM PHOSPHATE - Generic Drug Details
« Back to Dashboard
What are the generic drug sources for dexamethasone sodium phosphate and what is the scope of dexamethasone sodium phosphate freedom to operate?
Dexamethasone sodium phosphate
is the generic ingredient in thirteen branded drugs marketed by Ucb Inc, Merck, Cent Pharms, Abraxis Pharm, Fresenius Kabi Usa, Akorn, Aurobindo Pharma Ltd, Bel Mar, Dell Labs, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Organon Usa Inc, Pharmafair, Alcon, Sola Barnes Hind, Bausch And Lomb, Sandoz Inc, and Alcon Pharms Ltd, and is included in forty-seven NDAs. Additional information is available in the individual branded drug profile pages.
There are thirty-nine drug master file entries for dexamethasone sodium phosphate. Twenty-one suppliers are listed for this compound.
Summary for DEXAMETHASONE SODIUM PHOSPHATE
Pharmacology for DEXAMETHASONE SODIUM PHOSPHATE
|Merck||DECADRON||dexamethasone sodium phosphate||SOLUTION/DROPS;OPHTHALMIC, OTIC||011984-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Pharmafair||DEXAIR||dexamethasone sodium phosphate||OINTMENT;OPHTHALMIC||088071-001||Dec 28, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Lyphomed||DEXAMETHASONE SODIUM PHOSPHATE||dexamethasone sodium phosphate||INJECTABLE;INJECTION||087065-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Mylan Labs Ltd||DEXAMETHASONE SODIUM PHOSPHATE||dexamethasone sodium phosphate||INJECTABLE;INJECTION||040802-001||Aug 29, 2008||AP||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Merck||NEODECADRON||dexamethasone sodium phosphate; neomycin sulfate||OINTMENT;OPHTHALMIC||050324-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Wyeth Ayerst||DEXAMETHASONE SODIUM PHOSPHATE||dexamethasone sodium phosphate||INJECTABLE;INJECTION||085641-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Aurobindo Pharma Ltd||DEXAMETHASONE SODIUM PHOSPHATE||dexamethasone sodium phosphate||INJECTABLE;INJECTION||206781-001||Dec 1, 2015||AP||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|Alcon Pharms Ltd||NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE||dexamethasone sodium phosphate; neomycin sulfate||SOLUTION/DROPS;OPHTHALMIC||062714-001||Jul 21, 1986||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Organon Usa Inc||HEXADROL||dexamethasone sodium phosphate||INJECTABLE;INJECTION||014694-004||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|Bausch And Lomb||DEXAMETHASONE SODIUM PHOSPHATE||dexamethasone sodium phosphate||SOLUTION/DROPS;OPHTHALMIC, OTIC||040069-001||Jul 26, 1996||AT||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.